News-Medical.Net August 1, 2025
A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates.
Researchers at UT Southwestern Medical Centre used ChatGPT to assess whether patients were eligible to take part in clinical trials and were able to identify suitable candidates within minutes.
Clinical trials, which test new medications and procedures on the public, are vital for developing and validating new treatments. But many trials struggle to enrol enough participants. According to a recent study, up to 20% of National Cancer Institute (NCI)-affiliated trials fail due to low enrolment. This not only inflates costs and delays results, but also undermines the reliability of new...







